Archived explainer. For the current picture see today's GEHC page.
GE HEALTHCARE TECHNO (GEHC) is up +11.92% in the latest session. Our newswire has captured 23 stories on GEHC across 13 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100).
GEHC stock surged 11.92% to $71.75 on July 29, 2026, driven by better-than-expected earnings and reaffirmed guidance for 2026. The company reported adjusted earnings per share of $1.13 on revenue of $5.3 billion, exceeding estimates of $1.04 and $5.27 billion, respectively. Strong services sales and record orders contributed to the performance, while the company maintained its full-year adjusted EPS guidance of $4.80 to $5.00.
The stock opened with a 9.1% gap up at $69.95 and reached a session high of $73.00 shortly after the market opened. The rally followed GE HealthCare’s Q2 2026 earnings call, where the company highlighted record orders and a resilient backlog despite divergent performance across its business segments. The firm also confirmed it is reviewing strategic options for its Patient Care Solutions unit. The earnings report showed a 6.0% year-over-year revenue increase and a net margin of 9.1%. The company’s guidance for 3% to 4% organic sales growth through 2026 added to the optimism.
The intraday session saw heavy volume of 6.9 million shares, 1.4 times the 3-month average. The stock’s 52-week range is $58.75 to $89.77, and the current price of $71.75 is above the 8-session low of $64.11. Recent insider transactions include three directors buying shares totaling $805,000 in the last 90 days. On the retail side, social chatter on platforms like X has highlighted the earnings beat and guidance reaffirmation, with some traders calling the stock oversold.
The company has no upcoming earnings date beyond its FY2026 guidance, but coverage breadth remains at 23 stories from 13 sources in the last 36 hours. Investors should monitor any further developments in the strategic review of the Patient Care Solutions unit and the impact of ongoing cost pressures.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
GE HealthCare (GEHC) Q2 2026 earnings call recap: record orders/backlog, guidance maintained, PCS strategic review, and key risks—read the insights now.
GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call July 29, 2026 8:30 AM EDTCompany ParticipantsCarolynne Borders - Chief Investor Relations...
Cost increases have hit the company in 2026, but today's earnings report provides evidence of an oncoming improvement.
GE HealthCare tops quarterly estimates, weighs patient care unit sale
GE HealthCare's second quarter 2026 results reveal strong orders growth and a resilient backlog, despite divergent performance across its key business segments. The company reaffirms its 2026 guidance and continues to invest in innovation, while addressing ongoing challenges in Patient Care Solutions.
GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.
GE HealthCare (GEHC) stock jumped after the company posted better-than-expected Q2 2026 financials as its services sales beat estimates. Read more here.
More on GEHC: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier GEHC move explainers: 2026-07-30 · 2026-07-29